AWTAX
Price
$18.91
Change
-$0.00 (-0.00%)
Updated
Sep 8 closing price
Net Assets
477.42M
PGNAX
Price
$89.56
Change
+$1.79 (+2.04%)
Updated
Sep 8 closing price
Net Assets
978.45M
Interact to see
Advertisement

AWTAX vs PGNAX

AWTAX vs PGNAX Comparison Chart in %
View a ticker or compare two or three
VS
AWTAX vs. PGNAX commentary
Sep 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AWTAX is a Buy and PGNAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PGNAX has more cash in the bank: 978M vs. AWTAX (477M). AWTAX pays higher dividends than PGNAX: AWTAX (0.84) vs PGNAX (0.76). AWTAX was incepted earlier than PGNAX: AWTAX (18 years) vs PGNAX (37 years). AWTAX (1.49) is less costly to investors than PGNAX (1.26). PGNAX is a more actively managed with annual turnover of: 57.00 vs. AWTAX (29.00). AWTAX (6%) and PGNAX (6%) have equivalent initial investment costs. PGNAX has a lower initial minimum investment than AWTAX: PGNAX (1000) vs AWTAX (2500). PGNAX annual gain was more profitable for investors over the last year : 48.23 vs. AWTAX (-12.13). PGNAX return over 5 years is better than : 127.20 vs. AWTAX (-18.94).
AWTAXPGNAXAWTAX / PGNAX
Total Expense Ratio1.221.2697%
Annual Report Gross Expense Ratio1.491.26118%
Fund Existence18 years37 years-
Gain YTD-0.42125.745-2%
Front Load6%6%100%
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets477M978M49%
Annual Yield % from dividends0.840.76110%
Returns for 1 year-12.1348.23-25%
Returns for 3 years4.8266.737%
Returns for 5 years-18.94127.20-15%
Returns for 10 years40.36177.2523%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FOX58.24-0.18
-0.31%
Fox Corp
TRMD34.94-0.24
-0.68%
TORM plc
CBIO20.46-0.42
-2.01%
Crescent Biopharma Inc
CVGI3.17-0.07
-2.16%
Commercial Vehicle Group
CELZ1.08-0.03
-2.70%
Creative Medical Technology Holdings